QurientSelective CDK7 Inhibitor


 

Selective CDK7 Inhibitor

graph

Highly selective CDK7 inhibitors are under optimization for cancer.

Poster

1. Highly selective, orally available CDK7 inhibitor for cancer therapy (2017 AACR-NCI-EORTC poster)

information for download file